Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a stud

Approved

Classifications

MinEdu publication type
A1
Category
Artikkelit ja abstraktit
Refereed
Kyllä
Sub category
Tieteelliset aikakauslehtiartikkelit
Type
Alkuperäisartikkeli

Authors of the publication

Number of authors
13
Authors
Scheltens, P; Hallikainen, M; Grimmer, T; Duning, T; Gouw, AA; Teunissen, CE; Wink, AM; Maruff, P; Harrison, J; van Baal, CM; Bruins, S; Lues, I; Prins, ND
Local authors
Author
Hallikainen Merja

Publication channel information

Title of journal/series
Alzheimer's research and therapy
ISSN (electronic)
1758-9193
ISSN (linking)
1758-9193
Publication forum ID
70073
Publication forum level
1
Internationality
Yes

Detailed publication information

Publication year
2018
Reporting year
2018
Journal/series volume number
10
Journal/series issue number
1
Page numbers
107
DOI
10.1186/s13195-018-0431-6
Language of publication
English

Co-publication information

International co-publication
Yes
Co-publication with a company
Yes

Availability

Link to self-archived version
https://erepo.uef.fi/handle/123456789/7074

Classification and additional information

MinEdu field of science classification
3112 Neurosciences, 317 Pharmacy